These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32496578)

  • 21. When interferon tiptoes through COVID-19: Pernio-like lesions and their prognostic implications during SARS-CoV-2 infection.
    Damsky W; Peterson D; King B
    J Am Acad Dermatol; 2020 Sep; 83(3):e269-e270. PubMed ID: 32565206
    [No Abstract]   [Full Text] [Related]  

  • 22. Approach to Chilblains During the COVID-19 Pandemic [Formula: see text].
    Ladha MA; Luca N; Constantinescu C; Naert K; Ramien ML
    J Cutan Med Surg; 2020; 24(5):504-517. PubMed ID: 32741218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays.
    Merrill AE; Jackson JB; Ehlers A; Voss D; Krasowski MD
    J Appl Lab Med; 2020 Nov; 5(6):1351-1357. PubMed ID: 32717056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Promise and Peril of Antibody Testing for COVID-19.
    Abbasi J
    JAMA; 2020 May; 323(19):1881-1883. PubMed ID: 32301958
    [No Abstract]   [Full Text] [Related]  

  • 25. Can dried blood spots (DBS) contribute to conducting comprehensive SARS-CoV-2 antibody tests?
    Thevis M; Knoop A; Schaefer MS; Dufaux B; Schrader Y; Thomas A; Geyer H
    Drug Test Anal; 2020 Jul; 12(7):994-997. PubMed ID: 32386354
    [No Abstract]   [Full Text] [Related]  

  • 26. Serologic testing of coronaviruses from MERS-CoV to SARS-CoV-2: Learning from the past and anticipating the future.
    Al-Tawfiq JA; Memish ZA
    Travel Med Infect Dis; 2020; 37():101785. PubMed ID: 32534208
    [No Abstract]   [Full Text] [Related]  

  • 27. Pernio-like skin lesions associated with COVID-19: A case series of 318 patients from 8 countries.
    Freeman EE; McMahon DE; Lipoff JB; Rosenbach M; Kovarik C; Takeshita J; French LE; Thiers BH; Hruza GJ; Fox LP;
    J Am Acad Dermatol; 2020 Aug; 83(2):486-492. PubMed ID: 32479979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Free-floating right heart thrombus with pulmonary embolism in SARS-CoV-2 patient.
    Pla JJ; Rodriguez BF; Tirado CF
    Med Clin (Barc); 2020 Nov; 155(9):415-416. PubMed ID: 32868032
    [No Abstract]   [Full Text] [Related]  

  • 29. What to Expect from Antibody Assays of SARS-CoV-2?
    Yi X; Cao J
    J Appl Lab Med; 2020 Sep; 5(5):1126-1130. PubMed ID: 32589736
    [No Abstract]   [Full Text] [Related]  

  • 30. Covid-19 antibody tests: a briefing.
    Baraniuk C
    BMJ; 2020 Jun; 369():m2284. PubMed ID: 32580937
    [No Abstract]   [Full Text] [Related]  

  • 31. The Detection of Novel Coronavirus Antibodies is an Important Supplementary Detection Method for Screening of High-Risk Population.
    Wang D; Jia X; Huang T; Wang H; Li S; Ren T; Nie H; Chen Z; Song C; Zhou Y; Ma W; Shen H
    Clin Lab; 2020 Jul; 66(7):. PubMed ID: 32658430
    [No Abstract]   [Full Text] [Related]  

  • 32. Characterization of acute acral skin lesions in nonhospitalized patients: A case series of 132 patients during the COVID-19 outbreak.
    Fernandez-Nieto D; Jimenez-Cauhe J; Suarez-Valle A; Moreno-Arrones OM; Saceda-Corralo D; Arana-Raja A; Ortega-Quijano D
    J Am Acad Dermatol; 2020 Jul; 83(1):e61-e63. PubMed ID: 32339703
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay.
    Lau CS; Hoo SP; Yew SF; Ong SK; Lum LT; Heng PY; Tan JG; Wong MS; Aw TC
    J Appl Lab Med; 2020 Nov; 5(6):1313-1323. PubMed ID: 32717060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum IgA, IgM, and IgG responses in COVID-19.
    Ma H; Zeng W; He H; Zhao D; Jiang D; Zhou P; Cheng L; Li Y; Ma X; Jin T
    Cell Mol Immunol; 2020 Jul; 17(7):773-775. PubMed ID: 32467617
    [No Abstract]   [Full Text] [Related]  

  • 35. Vertical transmission of antibodies in infants born from mothers with positive serology to COVID-19 pneumonia.
    Vendola N; Stampini V; Amadori R; Gerbino M; Curatolo A; Surico D
    Eur J Obstet Gynecol Reprod Biol; 2020 Oct; 253():331-332. PubMed ID: 32878687
    [No Abstract]   [Full Text] [Related]  

  • 36. Labs scramble to produce new coronavirus diagnostics.
    Cohen J; Kupferschmidt K
    Science; 2020 Feb; 367(6479):727. PubMed ID: 32054740
    [No Abstract]   [Full Text] [Related]  

  • 37. Low prevalence of IgG antibodies to SARS-CoV-2 in cancer patients with COVID-19.
    Liu T; Zeng G; Tao H; Shi Y; ; Wang T; Liu T; Guo F; Zhou F; Wang X
    Int J Cancer; 2020 Dec; 147(11):3267-3269. PubMed ID: 32525566
    [No Abstract]   [Full Text] [Related]  

  • 38. [SARS-CoV-2, a new causal agent of Guillain-Barre syndrome].
    Redondo-Urda MJ; Rodríguez-Peguero FJ; Pérez-Gil O; Del Valle-Sánchez M; Carrera-Izquierdo M
    Rev Neurol; 2020 Oct; 71(7):275-276. PubMed ID: 32959360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 Serology: Much Hype, Little Data.
    Farnsworth CW; Anderson NW
    Clin Chem; 2020 Jul; 66(7):875-877. PubMed ID: 32343775
    [No Abstract]   [Full Text] [Related]  

  • 40. Unilateral conjunctivitis as first presentation of Coronavirus Disease 2019 (COVID-19): A telemedicine diagnosis.
    Daruich A; Martin D; Bremond-Gignac D
    J Fr Ophtalmol; 2020 May; 43(5):e167-e168. PubMed ID: 32327279
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.